SK283497B6 - Použitie N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrolidin- 1-yl)etyl]-2,2-difenylacetamidhydrochloridu na výrobu farmaceutického prostriedku - Google Patents

Použitie N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrolidin- 1-yl)etyl]-2,2-difenylacetamidhydrochloridu na výrobu farmaceutického prostriedku Download PDF

Info

Publication number
SK283497B6
SK283497B6 SK843-96A SK84396A SK283497B6 SK 283497 B6 SK283497 B6 SK 283497B6 SK 84396 A SK84396 A SK 84396A SK 283497 B6 SK283497 B6 SK 283497B6
Authority
SK
Slovakia
Prior art keywords
phenyl
methyl
ethyl
hydroxypyrrolidin
pain
Prior art date
Application number
SK843-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK84396A3 (en
Inventor
Andrew Barber
Christoph Seyfried
Gerd Bartoszyk
Rudolf Gottschlich
Original Assignee
Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschr�Nkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Publication of SK84396A3 publication Critical patent/SK84396A3/sk
Publication of SK283497B6 publication Critical patent/SK283497B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SK843-96A 1995-06-28 1996-06-27 Použitie N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrolidin- 1-yl)etyl]-2,2-difenylacetamidhydrochloridu na výrobu farmaceutického prostriedku SK283497B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19523502A DE19523502A1 (de) 1995-06-28 1995-06-28 Kappa-Opiatagonisten für entzündliche Darmerkrankungen

Publications (2)

Publication Number Publication Date
SK84396A3 SK84396A3 (en) 1997-04-09
SK283497B6 true SK283497B6 (sk) 2003-08-05

Family

ID=7765475

Family Applications (1)

Application Number Title Priority Date Filing Date
SK843-96A SK283497B6 (sk) 1995-06-28 1996-06-27 Použitie N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrolidin- 1-yl)etyl]-2,2-difenylacetamidhydrochloridu na výrobu farmaceutického prostriedku

Country Status (26)

Country Link
US (2) US5776972A (hu)
EP (1) EP0752246B1 (hu)
JP (2) JP4415075B2 (hu)
KR (1) KR100501612B1 (hu)
CN (1) CN1119147C (hu)
AR (1) AR004671A1 (hu)
AT (1) ATE214275T1 (hu)
AU (1) AU708699B2 (hu)
BR (1) BR9602915A (hu)
CA (1) CA2179955C (hu)
CO (1) CO4700454A1 (hu)
CZ (1) CZ289805B6 (hu)
DE (2) DE19523502A1 (hu)
DK (1) DK0752246T3 (hu)
ES (1) ES2171577T3 (hu)
HU (1) HU226976B1 (hu)
NO (1) NO309674B1 (hu)
PL (1) PL185537B1 (hu)
PT (1) PT752246E (hu)
RU (1) RU2190401C2 (hu)
SI (1) SI0752246T1 (hu)
SK (1) SK283497B6 (hu)
TR (1) TR199600497A2 (hu)
TW (1) TW430557B (hu)
UA (1) UA51615C2 (hu)
ZA (1) ZA965480B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
ATE235903T1 (de) * 1996-12-02 2003-04-15 Kyorin Seiyaku Kk Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren
US6133307A (en) * 1997-04-30 2000-10-17 Warner-Lambert Company Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists
BR9810706A (pt) * 1997-07-14 2000-08-08 Adolor Corp Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
DE19827633A1 (de) * 1998-04-20 1999-10-21 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
PL371596A1 (en) * 2002-05-17 2005-06-27 Merck Patent Gmbh Use of compounds that are effective as selective opiate receptor modulators
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
WO2005002622A1 (ja) * 2003-07-04 2005-01-13 Santen Pharmaceutical Co., Ltd. 疼痛閾値低下抑制剤
EP1680115A1 (en) * 2003-10-30 2006-07-19 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
US7160902B2 (en) * 2003-11-14 2007-01-09 Adolor Corporation Amide derivatives and methods of their use
US7642274B2 (en) 2004-07-02 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease
AU2008232954A1 (en) * 2007-03-30 2008-10-09 Tioga Pharmaceuticals Inc. Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
JP6138169B2 (ja) * 2012-03-05 2017-05-31 ドクター レディズ ラボラトリーズ リミテッド κオピオイド受容体（ＫＯＲ）アゴニストとしての置換複素環式アセトアミド
WO2015114660A1 (en) * 2014-01-24 2015-08-06 Cadila Healtchare Limited Novel heterobicyclic compounds as kappa opioid agonists
WO2018119108A1 (en) 2016-12-21 2018-06-28 Tioga Pharmaceuticals Inc. Splid pharmaceutical formulations of asimadoline
WO2019122361A1 (en) 2017-12-22 2019-06-27 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis
EP3932390A1 (en) 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
US5232266A (en) * 1989-07-24 1993-08-03 Mork William J Upholstered article of furniture with interchangeable seating module
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide

Also Published As

Publication number Publication date
DE59608861D1 (de) 2002-04-18
ES2171577T3 (es) 2002-09-16
EP0752246B1 (de) 2002-03-13
HUP9601798A1 (hu) 1998-03-30
RU2190401C2 (ru) 2002-10-10
TW430557B (en) 2001-04-21
JP2008201794A (ja) 2008-09-04
CA2179955A1 (en) 1996-12-29
ATE214275T1 (de) 2002-03-15
NO962720D0 (no) 1996-06-27
PL185537B1 (pl) 2003-05-30
KR970000230A (ko) 1997-01-21
CN1145781A (zh) 1997-03-26
SK84396A3 (en) 1997-04-09
DE19523502A1 (de) 1997-01-02
NO309674B1 (no) 2001-03-12
AR004671A1 (es) 1999-03-10
ZA965480B (en) 1997-01-27
SI0752246T1 (en) 2002-10-31
CZ186696A3 (en) 1997-01-15
HU226976B1 (en) 2010-04-28
CO4700454A1 (es) 1998-12-29
EP0752246A3 (de) 1997-02-26
UA51615C2 (uk) 2002-12-16
TR199600497A2 (tr) 1997-01-21
DK0752246T3 (da) 2002-05-13
JP5308056B2 (ja) 2013-10-09
EP0752246A2 (de) 1997-01-08
AU5616296A (en) 1997-01-09
US5977161A (en) 1999-11-02
AU708699B2 (en) 1999-08-12
KR100501612B1 (ko) 2005-10-12
CZ289805B6 (cs) 2002-04-17
JPH0920659A (ja) 1997-01-21
CN1119147C (zh) 2003-08-27
CA2179955C (en) 2008-10-07
NO962720L (no) 1996-12-30
JP4415075B2 (ja) 2010-02-17
US5776972A (en) 1998-07-07
BR9602915A (pt) 1998-04-22
PT752246E (pt) 2002-09-30
PL314996A1 (en) 1997-01-06

Similar Documents

Publication Publication Date Title
SK283497B6 (sk) Použitie N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroxypyrolidin- 1-yl)etyl]-2,2-difenylacetamidhydrochloridu na výrobu farmaceutického prostriedku
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
NO321606B1 (no) Pyrrolderivater og medisinsk sammensetning
AU653902B2 (en) 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1- carboxamide as an analgesic and anti-inflammatory agent
RU2174976C2 (ru) N-метил-n-/(1s-)-1-фенил-2-((3s)-3-гидроксипирролидин-1-ил)-этил/-2,2-дифенилацетамид
WO2006028500A1 (en) Sulpiride derivatives pharmaceutical compositions
US6300336B1 (en) Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them
JPS5842191B2 (ja) コウエンシヨウセイノジヒドロフランカン マタハ ジヒドロピランカンガンユウアリ−ルアルカンサンノ セイゾウホウ
CN115364101A (zh) 治疗糖尿病周围神经病变的方法和药物组合物
NO139733B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
US5876751A (en) Antispasmodic and antinflammatory composition and a process for the manufacture thereof
CA2153050C (en) Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
EP0868915A1 (en) An anti-spasmodic and antiinflammatory composition containing a NSAID, pentifenone and fenpiverinium
CN114349665A (zh) 二甲双胍焦谷氨酸晶体及其制备方法与应用
CN115006346A (zh) 精神疾病治疗剂的稳定化方法和包含阿米替林的组合物
US5897875A (en) Use of α,α-diphenylacetic acid-4-(N-methyl-piperidyl) ester as a spasmolytic analgesic
CN116211855A (zh) 12-表-15-欧乌头碱及其衍生物在制备镇痛药物中的应用
JPH01216931A (ja) 血中尿酸濃度低減用治療剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140627